MARATTO

review · Bulletin of Pharmaceutical Sciences Assiut

Exploring the Potential Hepatoprotective efficacy of Lepidium Sativum seeds: A Comprehensive Review

Abstract

Background: Chronic liver diseases are the leading cause of morbidity and mortality worldwide.Lepidium sativum (L. sativum) is a famous member of the Bras-sicaceae family that has been utilized for medicinal and culinary purposes for cen-turies. The hepatoprotective activity of various portions of the plant has been re-ported in several experimental and clinical trials. Aim: The current review study aimed to discuss the hepatoprotective effects of L. sativum seeds. Methods: The da-ta of this review were collected from English-language in-vivo and in-vitro studies published in electronic databases; with no time limit; including Web of Science, Scopus, MEDLINE, Google Scholar and PubMed. The searched keywords were “Lepidium sativum” and/or “chemical composition”, “Hepatoprotective”, “liver diseases”. Results: Lepidium sativum seeds significantly decreased the elevated in-flammatory markers and oxidative stress in hepatic tissues. The seed extract signifi-cantly lowered serum levels of ASP, ALT, and bilirubin. The potential molecular mechanism may be through upregulating Bcl-2 protein expression and downregu-lating caspase-3. Conclusion: Lepidium sativum seeds are promising hepatoprotec-tive natural remedy through their multi-targeted action on different pathophysio-logical mechanisms involved in liver diseases.

Research topics

  • Drug-Induced Hepatotoxicity and Protection
  • Natural Antidiabetic Agents Studies
  • Ethnobotanical and Medicinal Plants Studies

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/bfsa.2024.276705.2061

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.